Nicotinamide Riboside Clinical Trial for GWI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Nicotinamide Riboside Clinical Trial for GWI — Stella

Recruiting

Back to Gulf War Illness trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Nova Southeastern University, Fort Lauderdale, Florida

The Roskamp Institute, Sarasota, Florida

Key details

Sponsor

Roskamp Institute Inc.

Collaborators

United States Department of Defense, Nova Southeastern University

Enrollment target

~52 participants

Started

April 2022

Primary completion

April 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

47 Years – 70 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov